Company intelligence / Profile preview
Orchid Pharma
Chennai, Tamil Nadu, Indiaorchidpharma.com ↗
- Ownership
- Private
- Employees
- ~871
- Development stage
- Other
01
Overview
Orchid Pharma is a leading Indian pharmaceutical company with a global presence, specializing in the development and manufacture of APIs, finished dosage forms, and novel antibiotics. The company is notable for discovering Enmetazobactam, the first new chemical entity from India to be approved in the US, EU, and India. Its lead product ORBLICEF (Enmetazobactam + cefepime) has been launched in Europe and India with promising clinical results against resistant bacterial strains. The pipeline includes both proprietary molecules and generics across multiple therapeutic areas.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeAntibioticCombination drug
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Cipla – marketing partnership for ORBLICEF/Enmetazobactam-cefepime in India
Beyond the preview
Go deeper on Orchid Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orchid Pharma.